Key points from article :
Vitestro has unveiled Aletta, an autonomous robotic phlebotomy device designed to automate blood draws, reducing the workload on healthcare professionals and addressing staffing shortages. Named after Dr. Aletta Jacobs, the first female doctor in the Netherlands, the device allows nurses and phlebotomists to focus more on patient care while ensuring a smooth and efficient process.
Equipped with AI-powered Doppler ultrasound and imaging technology, Aletta accurately identifies veins and uses robotic-controlled needles to perform precise and consistent blood draws. The device integrates seamlessly into hospital and laboratory workflows, enhancing efficiency and increasing patient throughput.
Vitestro has launched Aletta commercially in Europe following its CE mark approval and is now working toward U.S. regulatory approval. The company is conducting a multi-center clinical trial in the U.S. to support broader adoption of this innovative medical robot.
